ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 15,122,528
- Share change
- +1,028,191
- Total reported value
- $963,007,127
- Put/Call ratio
- 32%
- Price per share
- $63.68
- Number of holders
- 200
- Value change
- +$64,529,569
- Number of buys
- 102
- Number of sells
- 89
Quarterly Holders Quick Answers
What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00182C103:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
11%
|
2,531,343
|
$174,991,742 | — | 31 Mar 2024 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
1,306,432
|
$90,313,644 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
4.3%
|
958,533
|
$66,263,386 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.7%
|
822,001
|
$56,824,929 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.7%
|
609,173
|
$42,112,128 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
574,838
|
$39,738,551 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
490,265
|
$33,892,019 | — | 31 Mar 2024 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
1.8%
|
402,204
|
$27,804,363 | — | 31 Mar 2024 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
1.8%
|
390,750
|
$27,012,548 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
339,364
|
$23,464,056 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.5%
|
324,042
|
$22,401,023 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
252,260
|
$17,438,734 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
246,156
|
$17,016,764 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
243,274
|
$16,817,532 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
232,190
|
$16,051,295 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.96%
|
213,899
|
$14,787,000 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.94%
|
210,026
|
$14,519,097 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.88%
|
196,483
|
$13,582,869 | — | 31 Mar 2024 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
0.87%
|
192,757
|
$13,325,000 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.81%
|
180,343
|
$12,467,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
163,346
|
$11,292,108 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.67%
|
150,000
|
$10,369,500 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.61%
|
135,902
|
$9,395,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
118,766
|
$8,210,294 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.53%
|
118,291
|
$8,177,457 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
117,526
|
$8,124,572 | — | 31 Mar 2024 | |
| James G. Marken |
3/4/5
|
SVP OPS & PROD DEV |
—
class O/S missing
|
117,829
|
$7,977,023 | — | 07 Jun 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.52%
|
115,071
|
$7,954,858 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.48%
|
106,675
|
$7,374,441 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.39%
|
87,699
|
$6,062,632 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.39%
|
87,354
|
$6,038,782 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.38%
|
83,944
|
$5,803,049 | — | 31 Mar 2024 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.36%
|
80,861
|
$5,589,921 | — | 31 Mar 2024 | |
| MARATHON CAPITAL MANAGEMENT |
13F
|
Company |
0.32%
|
71,170
|
$4,919,982 | — | 31 Mar 2024 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.3%
|
67,510
|
$4,666,966 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
67,353
|
$4,656,113 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
65,790
|
$4,548,063 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.29%
|
64,834
|
$4,481,974 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.25%
|
55,683
|
$3,849,366 | — | 31 Mar 2024 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.23%
|
50,722
|
$3,506,411 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
50,521
|
$3,492,517 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.22%
|
50,114
|
$3,464,381 | — | 31 Mar 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.22%
|
50,110
|
$3,464,103 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.21%
|
47,147
|
$3,259,272 | — | 31 Mar 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.2%
|
43,500
|
$3,007,155 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.19%
|
41,855
|
$2,893,434 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.18%
|
40,730
|
$2,815,665 | — | 31 Mar 2024 | |
| Robert E. Brown Jr. |
3/4/5
|
Director |
—
class O/S missing
|
49,021
|
$2,766,745 | — | 27 Apr 2022 | |
| COMERICA BANK |
13F
|
Company |
0.16%
|
36,663
|
$2,534,486 | — | 31 Mar 2024 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q2 2024
As of 30 Jun 2024,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,122,528 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Rubric Capital Management LP, Global Alpha Capital Management Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Deep Track Capital, LP, TANG CAPITAL MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
200
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
195
Q2 2024 holders
200
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.